JPY 1209.0
(-0.08%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -1.7 Billion | -38.2 Billion | 12 Billion | 29.46 Billion | -14.19 Billion | -8.68 Billion |
Net Income | 1.05 Billion | 1.66 Billion | 1.21 Billion | 1.53 Billion | 1.36 Billion | 1.46 Billion |
Depreciation & Amortization | 745 Million | 812 Million | 821 Million | 758 Million | 889 Million | 913 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -3.3 Billion | -40.03 Billion | 8.84 Billion | 27.67 Billion | -18.8 Billion | -1.97 Billion |
Other non-cash items | 1.28 Billion | -648 Million | 1.11 Billion | -507 Million | 2.35 Billion | -9.09 Billion |
Investing Cash Flow | 4.92 Billion | 11.73 Billion | -8.64 Billion | -17.47 Billion | 16.07 Billion | 22.2 Billion |
Investments in PPE | -1.22 Billion | -386 Million | -571 Million | -203 Million | -227 Million | -582 Million |
Acquisitions | 33 Million | -45 Million | 7.56 Billion | -266 Million | -202 Million | -457 Million |
Investment purchases | -33.43 Billion | -30.58 Billion | -44.42 Billion | -47.85 Billion | -23.94 Billion | -10.06 Billion |
Sales/Maturities of investments | 31.18 Billion | 42.74 Billion | 36.86 Billion | 30.84 Billion | 40.44 Billion | 33.31 Billion |
Other Investing Activities | -3.06 Billion | -1 Million | -8.07 Billion | 1 Million | -2 Million | -1 Million |
Financing Cash Flow | 48.96 Billion | -471 Million | -467 Million | -467 Million | -516 Million | -3.56 Billion |
Debt repayment | -1 Million | -2 Million | - | -58.7 Billion | -100 Million | -3 Billion |
Dividends payments | -467 Million | -470 Million | -466 Million | -466 Million | -514 Million | -562 Million |
Common Stock Repurchased | - | - | - | - | -1 Million | -1 Million |
Common Stock Issuance | - | - | - | - | 100 Million | - |
Other Financing Activities | -1 Million | 1 Million | -1 Million | 58.69 Billion | -1 Million | -1 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 9.51 Billion | -40.03 Billion | 8.84 Billion | 27.67 Billion | -18.8 Billion | -13.96 Billion |
Cash at beginning of period | 72.57 Billion | 99.51 Billion | 96.63 Billion | 85.11 Billion | 83.74 Billion | 73.78 Billion |
Cash at end of period | 124.76 Billion | 72.57 Billion | 99.51 Billion | 96.63 Billion | 85.11 Billion | 83.74 Billion |
Capital Expenditure | -1.22 Billion | -386 Million | -571 Million | -203 Million | -227 Million | -582 Million |
Effect of forex changes on cash | - | - | -1 Million | - | - | - |
Net cash flow / Change in cash | 52.18 Billion | -26.94 Billion | 2.88 Billion | 11.51 Billion | 1.37 Billion | 9.96 Billion |
Free Cash Flow | -2.93 Billion | -38.58 Billion | 11.42 Billion | 29.25 Billion | -14.41 Billion | -9.26 Billion |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 569 Million | 104 Million | 1.05 Billion | 202 Million | 305 Million | 445 Million |
Depreciation & Amortization | - | - | 745 Million | 188 Million | 186 Million | 183 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -3.3 Billion | - | - | - |
Other non-cash items | -569 Million | -104 Million | 1.28 Billion | -202 Million | -305 Million | -445 Million |
Investing Cash Flow | - | - | 4.92 Billion | - | - | - |
Investments in PPE | - | - | -1.22 Billion | - | - | - |
Acquisitions | - | - | 33 Million | - | - | - |
Investment purchases | - | - | -33.43 Billion | - | - | - |
Sales/Maturities of investments | - | - | 31.18 Billion | - | - | - |
Other Investing Activities | - | - | -3.06 Billion | - | - | - |
Financing Cash Flow | - | - | 48.96 Billion | - | - | - |
Debt repayment | - | - | -1 Million | - | - | - |
Dividends payments | - | - | -467 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -1 Million | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | 9.51 Billion | - | - | - |
Cash at beginning of period | - | - | 72.57 Billion | - | - | - |
Cash at end of period | - | - | 124.76 Billion | 376 Million | 372 Million | 366 Million |
Capital Expenditure | - | - | -1.22 Billion | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | 52.18 Billion | 376 Million | 372 Million | 366 Million |
Free Cash Flow | - | - | -2.93 Billion | 376 Million | 372 Million | 366 Million |
PATELENG
003012
PHR
CUBI
300953
DRDNF